NGR and isoDGR are separate moieties binding to different receptors

Blood

Volumn 113, Issue 21, 2009, Pages 5366-

  Rizzardi, Gian Paolo ^a   Bordignon, Claudio ^b  

^a MOLMED S P A   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARAGINYLGLYCYLARGININE; ISOASPARTYLGLYCYLARGININE; MICROSOMAL AMINOPEPTIDASE; THROMBOPLASTIN; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; INTEGRIN; NGR PEPTIDE; OLIGOPEPTIDE;

DEAMINATION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ENDOTHELIUM; HUMAN; LETTER; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN MOTIF; TUMOR THROMBUS; TUMOR VASCULARIZATION; DRUG DELIVERY SYSTEM; METABOLISM; METHODOLOGY; NOTE;

DRUG DELIVERY SYSTEMS; HUMANS; INTEGRINS; OLIGOPEPTIDES; RESEARCH DESIGN;

EID: 67149122416     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-02-207068     Document Type: Letter

References (5)

1. Bieker R, Kessler T, Schwoppe C, et al. Infarction of tumor vessels by NGR-peptide directed targeting of tissue factor. Experimental results and first-in-man experience. Blood. 2009;113:5019-5027.
2. Corti A, Curnis F, Arap W, Pasqualini R. The neovasculature homing motif NGR: more than meets the eye. Blood. 2008;112:2628-2635.
3. Curnis F, Longhi R, Crippa L, et al. Spontaneous formation of L-isoaspartate and gain of function in fibronectin. J Biol Chem. 2006;281:36466-36476. (Pubitemid 46041380)
4. Pasqualini R, Koivunen E, Kain R, et al. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 2000;60:722-727. (Pubitemid 30094573)
5. Spitaleri A, Mari S, Curnis F, et al. Structural basis for the interaction of isoDGR with the RGD-binding site of alphavbeta3 integrin. J Biol Chem. 2008;283:19757-19768.